International Clinical Trial: A randomised Phase III trial to assess whether radiotherapy with radiosensitisers is beneficial in patients with high-risk non-muscle invasive bladder cancer when compared with the standard of care treatment, Bacillus Calmette-Guerin

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN16345179) titled 'A randomised Phase III trial to assess whether radiotherapy with radiosensitisers is beneficial in patients with high-risk non-muscle invasive bladder cancer when compared with the standard of care treatment, Bacillus Calmette-Guerin' on Oct. 13.

Study Type: Interventional

Study Design: Open randomized controlled parallel-group trial (Safety, Efficacy)

Primary Sponsor: The Christie NHS Foundation Trust

Condition: High-risk non-muscle invasive bladder cancer Cancer

Intervention: This trial is an unblinded randomised Phase III trial. Patients will randomly be allocated to one of two trials arms. The first arm...